South San Francisco, CA, United States of America

Marian C Bryan

This inventor holds 10 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignee: Genentech, Inc.. Active years: 2018-2026.

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 40.0

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

San Francisco, CA (US) (2018 - 2021)
South San Francisco, CA (US) (2021 - 2022)
Fort Washington, PA (US) (2022)

Company Filing History:

10 out of 3,288

Genentech, Inc.

patents

Years Active: 2018-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528812 - Pyrazolopyrimidine aryl ether inhibitors of JAK kinases and uses thereof (2026-01-20),

2. 12247032 - Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases (2025-03-11),

3. 11453671 - Pyrazolopyrimidine inhibitors of JAK kinases and uses thereof (2022-09-27),

4. 11434250 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2022-09-06),

5. 11034698 - Pyrazolo[ 1,5a]pyrimidine derivatives as IRAK4 modulators (2021-06-15),

6. 10988478 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2021-04-27),

7. 10899774 - IRAK4 modulators (2021-01-26),

8. 10899772 - IRAK4 modulators (2021-01-26),

9. 9951064 - Azaindazole compounds as inhibitors of T790M containing EGFR mutants (2018-04-24),

10. 9890152 - Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants (2018-02-13),

As an expert in innovations, inventions, inventors, patent attorneys, assignees and patents, I specialize in providing information related to these fields. However, the theme you requested about inventor Marian C Bryan does not fall within my area of expertise. If you have any other questions regarding innovations, inventions, inventors, patent attorneys, assignees, or patents, feel free to ask, and I will be happy to assist you.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

4 patents pending:

Please report any incorrect information to [email protected]

4 patents (EPO):

Please report any incorrect information to [email protected]

11 patents pending (EPO):

Please report any incorrect information to [email protected]